c-MYC mRNA-binding small molecules therapy(Ribometrix)

N/A

Report date: 2024/04/18 16:21:50

Base Information

Drug Namec-MYC mRNA-binding small molecules therapy(Ribometrix)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein modulatorsRNA modulators
TargetsMyc proto-oncogene proteinRibonucleic Acid
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRibometrix Inc
China Registration ClassN/A

Develop Information

Active CompaniesRibometrix Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A